<DOC>
	<DOC>NCT02013609</DOC>
	<brief_summary>To investigate the efficacy and safety of flexibly dosed adjunctive brexpiprazole treatment in active adults with MDD, 18 to 35 years old, who are experiencing an inadequate selective serotonin reuptake inhibitor (SSRI)/serotonin norepinephrine reuptake inhibitor (SNRI) response in a school or work environment.</brief_summary>
	<brief_title>Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Brexpiprazole</mesh_term>
	<criteria>Main Have a diagnosis of a single or recurrent, nonpsychotic episode of MDD as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSMIVTR) and confirmed by both the Mini International Neuropsychiatric Interview (M.I.N.I.) and an adequate clinical psychiatric evaluation. Have a treatment history of an inadequate ADT response to at least 1 ADT (but not &gt; 3) for the current episode. Have received a single, trialapproved, SSRI or SNRI at an adequate dose for ≥ 6 weeks prior to screening. Are 18 to 35 years old at the time of consent (inclusive, and outpatients only). Are (and will be) working 20 hours or more per week or a student taking 6 credit hours or more during the trial period, however minor deviations from the "parttime" concept may be acceptable on a casebycase basis based on approval of the medical monitor. Have a Hamilton Depression Rating Scale (HAMD) 17item Total Score ≥ 18 at screening and baseline. Have a Sheehan Disability Scale (SDS) 3item mean score ≥ 5 at baseline. Main Subjects with any of the following current Axis I DSMIVTR diagnoses: delirium, dementia, amnestic, or other cognitive disorders; schizophrenia, schizoaffective disorder, or other psychotic disorders; bipolar I disorder, bipolar II disorder, or bipolar disorder not otherwise specified (NOS); eating disorders (including anorexia nervosa or bulimia); obsessive compulsive disorder; panic disorder; posttraumatic stress disorder; and attention deficit hyperactivity disorder. Subjects with any of the following current Axis II DSMIVTR diagnoses: borderline, antisocial, paranoid, schizoid, schizotypal or histrionic personality disorders, or mental retardation.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>Major depressive disorder</keyword>
	<keyword>Anxiety Symptoms</keyword>
	<keyword>School, Work environment</keyword>
	<keyword>Mental Disorders</keyword>
	<keyword>Psychotic Disorders</keyword>
	<keyword>antipsychotic</keyword>
</DOC>